FDA Inspection
Greater Baltimore Medical CenterGreater Baltimore Medical Center – FDA Inspection, Jun 15, 2012
Record Details
This FDA Inspection record concerns Greater Baltimore Medical Center, with an inspection on June 15, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- June 15, 2012
- Product Type
- Biologics
View Company Profile
ID · 429db247-3932-41c5-85e9-f83ff23b9fc7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 786212
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 211.188(b)(2)Identity of major equipment and lines used
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Greater Baltimore Medical Center
8| Date | Classification | Office | Project area |
|---|---|---|---|
| February 5, 2026 | NAI | Blood and Blood Products | |
| October 26, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 1, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 8, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 14, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Greater Baltimore Medical Center
- FDA Inspection 1305080 - 2026-02-05
- FDA Inspection 1221203 - 2023-10-26
- FDA Inspection 1121801 - 2019-11-01
- FDA Inspection 1038518 - 2017-12-08
- FDA Inspection 982274 - 2016-07-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.